Study Explores PDLIM2 as Prognostic Biomarker and Treatment Target in Lung Adenocarcinoma
Lung adenocarcinoma is one of the most common forms of lung cancer and remains a major cause of cancer-related death worldwide. Although advances in imaging, molecular testing and targeted treatment have...
Read moreDetails





















